Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
69,631
Sort by:
Global Alpha-glucosidase Inhibitors Market Size study, by Drug Type (Acarbose, Miglitol, Voglibose), by Indication (Type 2 Diabetes Mellitus, Pre-diabetes), by Type (Branded, Generic), by Distribution Channel (Hospital, Retail, Online Pharmacies), and Regional Forecasts 2022-2032
US$ 3,750.00
Global Alpha-glucosidase Inhibitors Market is valued approximately at USD 3.3 billion in 2023 and is anticipated to grow with a steady compound annual growth rate of more than 3.20% over the forecast...
May 2025
285 pages
Global Aminophylline Market Size study, by Dosage Form (Injection, Tablet, Solution), Medication Type (Generics, Branded), Application (Asthma, Emphysema, COPD), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Aminophylline Market is valued at approximately USD 0.35 billion in 2023 and is projected to grow at a slow yet consistent compound annual growth rate (CAGR) of 2.10% over the forecast peri...
May 2025
285 pages
Global Asthma Therapeutics Market Size study, by Drug Class, Treatment Type, Route of Administration (Inhaled, Oral, Injectable), Distribution Channel, End-use (Hospitals & clinics, ASCs, Homecare settings) and Regional Forecasts 2022-2032
US$ 3,750.00
Global Asthma Therapeutics Market is valued approximately at USD 25.7 billion in 2023 and is anticipated to grow with a steady compound annual growth rate of more than 4.40% over the forecast period 2...
May 2025
285 pages
Global Basal Cell Carcinoma Treatment Market Size study, by System (Hardware, Software, Services), by Treatment Type (Surgery, Radiotherapy, Topical Chemotherapy, Intralesional Injections, Oral Medications, Chemical Peeling Treatment) and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Basal Cell Carcinoma Treatment Market is valued at approximately USD 2.96 billion in 2023 and is projected to grow at a strong CAGR of 10.44% during the forecast period 2024–2032. Basal cel...
May 2025
285 pages
Global Biologics Market Size study, by Product (Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cellular-Based Biologics, Gene-Based Biologics, and Other Products), by Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Other Applications) and Regional Forecasts 2022-2032
US$ 3,750.00
Global Biologics Market is valued at approximately USD 338.04 billion in 2023 and is anticipated to grow with a robust compound annual growth rate of more than 10.49% over the forecast period 2024–203...
May 2025
285 pages
Global Biosimilar Monoclonal Antibodies Market Size study, by Type (Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others), by Indication (Oncology, Autoimmune Diseases, Others), by End User (Hospitals, Cancer Treatment Centers, Others), and Regional Forecasts 2022-2032
US$ 3,750.00
Global Biosimilar Monoclonal Antibodies Market is valued approximately at USD 10.63 billion in 2023 and is anticipated to grow with a remarkable CAGR of 22.20% over the forecast period 2024–2032. The...
May 2025
285 pages
Global Carbapenem Market Size study, by Drug Class (Meropenem, Imipenem, Ertapenem, Doripenem), by Application (Urinary Tract, Bloodstream, & Intra-Abdominal Infections, Bacterial Meningitis), by Distribution Channel, and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Carbapenem Market is valued approximately at USD 4.00 billion in 2023 and is anticipated to grow with a steady CAGR of more than 5.00% over the forecast period 2024-2032. Carbapenems, a cla...
May 2025
285 pages
Global Crohn's Disease Therapeutics Market Size study, by Treatment (Medication [Anti-inflammatory Agents, Immunosuppressants, Antibiotics, Antipyretics], Nutritional Therapy, Surgery), Dosage Form (Oral, Parenteral), Age Group, End-use, and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Crohn’s Disease Therapeutics Market is valued at approximately USD 13.3 billion in 2023 and is projected to expand at a compound annual growth rate of more than 4.00% from 2024 to 2032. Cro...
May 2025
285 pages
Global Cryptococcosis Therapeutics Market Size study, by Treatment (Flucytosine, Amphotericin B, Fluconazole), by Route of Administration (Oral, Intravenous, Inhalation), by Drug Type (Branded, Generics), by Distribution Channel, and Regional Forecasts 2022–2032
US$ 3,750.00
Global Cryptococcosis Therapeutics Market is valued approximately at USD 4.8 billion in 2023 and is anticipated to grow with a compound annual growth rate (CAGR) of 4.70% over the forecast period 2024...
May 2025
285 pages
Global DNA Repair Drugs Market Size study, by Drug Type (Olaparib, Rucaparib, Niraparib), by Application (Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer), by Route of Administration (Oral, Parenteral), by Distribution Channel, and Regional Forecasts 2022-2032
US$ 3,750.00
Global DNA Repair Drugs Market is valued approximately at USD 6.8 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.90% over the forecast period 2024-2032. DNA repai...
May 2025
285 pages
